Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-19
2007-06-19
Chism, B. Dell (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600
Reexamination Certificate
active
11049063
ABSTRACT:
The present invention is directed to a prevention and treatment for dermatological disorders. One aspect of this invention involves a dermatological treatment comprising one or more polypeptides with an amino acid sequence including KPV (SEQ. ID. NO. 1), MEHFRWGKPV (SEQ. ID. NO. 2), HFRWGKPV (SEQ. ID. NO. 3), or SYSMEHFRWGKPV (SEQ. ID. NO. 4) for the treatment and prevention of dermatological disorders. The polypeptides are at a level to effectively treat the cutaneous inflammation and are carried by a carrier. The one or more polypeptides can also be a dimer formed from any of the amino acid sequence above.
REFERENCES:
Ichiyama et al. 2000, Ann. N.Y. Acad. Sci., vol. 917, pp. 221-226.
Saunders et al., 2001, J. Biol. Chem., vol. 276, No. 22, pp. 18897-18904.
The Merk Manual, 16th Edition, 1992, pp. 2407-2409.
Stedman, T.L. 2000. Stedman's Medical Dictionary. Lippincott Williams & Wilkins, Philadelphia. xxxvi, 2098 pp. 897-898.
Catania Anna P.
Lipton James M.
Chism B. Dell
Dykema Gossett PLLC
Zengen, Inc.
Zinkl Gregory M.
LandOfFree
Use of KPV tripeptide for dermatological disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of KPV tripeptide for dermatological disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of KPV tripeptide for dermatological disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3862600